Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Blaser

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 22, 2026
Single-Cell RNA-seq Analysis Reveals Distinct Tumor and Immunosuppressive T-Cell Phenotypes in Patients with CLL Treated with IbrutinibShanmugapriya Thangavadivel, Jami Shaffer, Shrilekha Misra, et al.
The Journal of Clinical Investigation|August 25, 2007
FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphocytic leukemiaPaolo Neviani, Ramasamy Santhanam, Joshua J Oaks, et al.
American Journal of Hematology|May 5, 2025
PIEZO1 Activation-Mediated Generation of Transgene-Free Long-Term Hematopoietic Stem CellsGiorgia Scapin, Jennifer L Cillis, Marie C Goulard, et al.
Experimental Hematology & Oncology|July 13, 2022
A sumoylation program is essential for maintaining the mitotic fidelity in proliferating mantle cell lymphoma cellsWalter Hanel, Pushpa Lata, Youssef Youssef, et al.
Cancer Immunology, Immunotherapy : CII|April 15, 2024
CD200 is overexpressed in the pancreatic tumor microenvironment and predictive of overall survivalJessica Wedig, Shrina Jasani, Debasmita Mukherjee, et al.
Blood Advances|October 2, 2023
Resistance to PRMT5-targeted therapy in mantle cell lymphomaMackenzie Elizabeth Long, Shirsha Koirala, Shelby Sloan, et al.
Cell Reports|May 20, 2023
Microenvironmental control of hematopoietic stem cell fate via CXCL8 and protein kinase CVera Binder, Wantong Li, Muhammad Faisal, et al.
Blood Cancer Discovery|September 13, 2021
Inhibition of MET Signaling with Ficlatuzumab in Combination with Chemotherapy in Refractory AML: Clinical Outcomes and High-Dimensional AnalysisVictoria E Wang, Bradley W Blaser, Ravi K Patel, et al.
JCI Insight|November 8, 2024
Inhibition of Bruton's tyrosine kinase with PD-1 blockade modulates T cell activation in solid tumorsEmily Schwarz, Brooke Benner, Robert Wesolowski, et al.
Nature Communications|January 7, 2023
Dysregulation of PRMT5 in chronic lymphocytic leukemia promotes progression with high risk of Richter's transformationZachary A Hing, Janek S Walker, Ethan C Whipp, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 22, 2026
Single-Cell RNA-seq Analysis Reveals Distinct Tumor and Immunosuppressive T-Cell Phenotypes in Patients with CLL Treated with IbrutinibShanmugapriya Thangavadivel, Jami Shaffer, Shrilekha Misra, et al.
The Journal of Clinical Investigation|August 25, 2007
FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphocytic leukemiaPaolo Neviani, Ramasamy Santhanam, Joshua J Oaks, et al.
American Journal of Hematology|May 5, 2025
PIEZO1 Activation-Mediated Generation of Transgene-Free Long-Term Hematopoietic Stem CellsGiorgia Scapin, Jennifer L Cillis, Marie C Goulard, et al.
Experimental Hematology & Oncology|July 13, 2022
A sumoylation program is essential for maintaining the mitotic fidelity in proliferating mantle cell lymphoma cellsWalter Hanel, Pushpa Lata, Youssef Youssef, et al.
Cancer Immunology, Immunotherapy : CII|April 15, 2024
CD200 is overexpressed in the pancreatic tumor microenvironment and predictive of overall survivalJessica Wedig, Shrina Jasani, Debasmita Mukherjee, et al.
Blood Advances|October 2, 2023
Resistance to PRMT5-targeted therapy in mantle cell lymphomaMackenzie Elizabeth Long, Shirsha Koirala, Shelby Sloan, et al.
Cell Reports|May 20, 2023
Microenvironmental control of hematopoietic stem cell fate via CXCL8 and protein kinase CVera Binder, Wantong Li, Muhammad Faisal, et al.
Blood Cancer Discovery|September 13, 2021
Inhibition of MET Signaling with Ficlatuzumab in Combination with Chemotherapy in Refractory AML: Clinical Outcomes and High-Dimensional AnalysisVictoria E Wang, Bradley W Blaser, Ravi K Patel, et al.
JCI Insight|November 8, 2024
Inhibition of Bruton's tyrosine kinase with PD-1 blockade modulates T cell activation in solid tumorsEmily Schwarz, Brooke Benner, Robert Wesolowski, et al.
Nature Communications|January 7, 2023
Dysregulation of PRMT5 in chronic lymphocytic leukemia promotes progression with high risk of Richter's transformationZachary A Hing, Janek S Walker, Ethan C Whipp, et al.
Pageof 5